Franklin Resources’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,113,166
Closed -$4.61M 1558
2017
Q1
$4.61M Hold
1,113,166
﹤0.01% 1120
2016
Q4
$4.8M Sell
1,113,166
-36,767
-3% -$238K ﹤0.01% 1090
2016
Q3
$11.3M Hold
1,149,933
0.01% 953
2016
Q2
$6.51M Hold
1,149,933
﹤0.01% 1052
2016
Q1
$8.76M Hold
1,149,933
﹤0.01% 1008
2015
Q4
$15.3M Hold
1,149,933
0.01% 912
2015
Q3
$18.9M Sell
1,149,933
-109,317
-9% -$2.24M 0.01% 859
2015
Q2
$28.3M Buy
1,259,250
+17,533
+1% +$277K 0.01% 800
2015
Q1
$12.1M Buy
1,241,717
+588,417
+90% +$5.77M 0.01% 1007
2014
Q4
$7.45M Hold
653,300
﹤0.01% 1106
2014
Q3
$7.53M Sell
653,300
-92,800
-12% -$1.42M ﹤0.01% 1095
2014
Q2
$14.5M Buy
746,100
+36,667
+5% +$647K 0.01% 964
2014
Q1
$12.7M Buy
709,433
+411,366
+138% +$6.75M 0.01% 969
2013
Q4
$3.15M Buy
+298,067
New +$3.33M ﹤0.01% 1214

Other funds holding CASC